Our results showed that ISG12a decreased in hepatocellular carcinoma and gastric cancer tissues compared with adjacent nontumorous tissues and it was consistently highly expressed in sensitive cells compared to that in resistant cells. This evidence concerns the gene IFI27 and hepatocellular carcinoma.